This is a review about E6, based on 2 published articles, using E6 antibody in all methods. It is aimed to help Labome visitors find the most suited E6 antibody.
  • immunohistochemistryIn 2003, M R Pillai et al. used EMD Millipore E6 antibody to study the transformation of cervical tissue to cancer mediated by expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus [ncbi , more ].
Santa Cruz Biotechnology
  • ChIP assayIn 2003, Tim Veldman et al. employed Santa Cruz Biotechnology E6 antibody to human papillomavirus E6 association with Myc proteins in vivo, binding to and cooperatively activating the telomerase reverse transcriptase promoter [ncbi , more ].
  • immunoprecipitationIn 2003, Tim Veldman et al. employed Santa Cruz Biotechnology E6 antibody to human papillomavirus E6 association with Myc proteins in vivo, binding to and cooperatively activating the telomerase reverse transcriptase promoter [ncbi , more ].
  • western blotIn 2003, Tim Veldman et al. employed Santa Cruz Biotechnology E6 antibody to human papillomavirus E6 association with Myc proteins in vivo, binding to and cooperatively activating the telomerase reverse transcriptase promoter [ncbi , more ].
Articles Reviewed
  1. M R Pillai et al. (2003). "Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer".PMID 12890803
  2. Tim Veldman et al. (2003). "Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter".PMID 12821782